Novozymes’ $12.3 Billion Merger with Chr. Hansen

Simpson Thacher represented Gordon Dyal & Co. in the transaction.Novozymes A/S announced its definitive agreement to acquire Chr. Hansen Holding A/S (“Chr. Hansen”) in a statutory merger…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here